Literature DB >> 6334976

Incidence of severe dementia in an urban sample followed from 70 to 79 years of age.

L V Nilsson.   

Abstract

The incidence of severe dementia between the age of 70 and 79 years was studied in a representative urban sample. The study comprised 385 subjects at 70 and sufficient information was obtained in 94.5% in the age interval 70-75 and in 89.2% in the age interval 75-79. A case was defined by absence of symptoms of severe dementia at the beginning of the interval and by disorientation and/or severe memory impairment in psychiatric interviews at the age of 75 or 79, or the same signs noted in case records from the intervals studied. In all, 43 subjects developed severe dementia. When mortality was taken into account the annual incidence rates were 17.7 +/- 10.7/1,000 in the 5-year interval between 70 and 75 and 32.3 +/- 16.9/1,000 in the 4-year interval between 75 and 79 in men compared with 5.0 +/- 4.9/1,000 and 25.3 +/- 11.3/1,000 respectively in women. There were no significant differences between men and women with regard to the incidence rates of all severe dementias or of etiological subgroups. There was a high degree of institutionalization. Most studies from Scandinavian countries have reported lower incidence figures.

Entities:  

Mesh:

Year:  1984        PMID: 6334976     DOI: 10.1111/j.1600-0447.1984.tb01237.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

1.  A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.

Authors:  Ruth Peters; Nigel Beckett; Maria Nunes; Astrid Fletcher; Françoise Forette; Christopher Bulpitt
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Incidence of dementia in a Munich community sample of the oldest old.

Authors:  M M Fichter; H Schröppel; I Meller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

3.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Authors:  R Brookmeyer; S Gray; C Kawas
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

Review 4.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

5.  Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88.

Authors:  G McGonigal; B Thomas; C McQuade; J M Starr; W J MacLennan; L J Whalley
Journal:  BMJ       Date:  1993-03-13

6.  Senile dementia of the Alzheimer type in the Lundby Study. I. A prospective, epidemiological study of incidence and risk during the 15 years 1957-1972.

Authors:  O Hagnell; A Franck; A Gräsbeck; R Ohman; L Ojesjö; L Otterbeck; B Rorsman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

7.  Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA).

Authors:  Badri N Vardarajan; Kelley M Faber; Thomas D Bird; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Robert A Sweet; Rafael Lantigua; Martin Z Medrano; Ruth Ottman; Daniel J Schaid; Tatiana M Foroud; Richard Mayeux
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

Review 8.  Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias.

Authors:  A F Jorm
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 9.  The epidemiology of primary degenerative dementia and related neurological disorders.

Authors:  B Cooper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

10.  Postmenopausal hormone therapy and Alzheimer disease: A prospective cohort study.

Authors:  Bushra Imtiaz; Marjo Tuppurainen; Toni Rikkonen; Miia Kivipelto; Hilkka Soininen; Heikki Kröger; Anna-Maija Tolppanen
Journal:  Neurology       Date:  2017-02-15       Impact factor: 9.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.